Cancer survivor-turned-researcher advocates for patient access to medical notes
In 2005, the number of internet users reached 1 billion. In 2007, the first iPhone was introduced. In 2008, Liz Salmi was... Read More
Shorter, stronger radiation course effective for high-risk prostate cancer
Stereotactic body radiotherapy appeared safe and effective for men with high-risk prostate cancer, according to an analysis of data from... Read More
FDA grants priority review to relugolix for advanced prostate cancer
The FDA granted priority review to relugolix for treatment of men with advanced prostate cancer. Read here.
Invasive prostate cancer incidence rising among young men; cause elusive
Incidence of prostate cancer among adolescents and young adults has increased in the United States and many other countries during... Read More
Study offers insight into correlation between infertility, prostate cancer risk
Men who fathered children through assisted reproduction methods demonstrated higher risk for prostate cancer and early-onset prostate cancer than men... Read More
High-dose radiation effective in oligometastatic prostate cancer
Stereotactic ablative radiation appeared to be an effective and safe treatment for men with oligometastatic prostate cancer, with significant benefits... Read More
Stereotactic body radiotherapy safe, effective for low to intermediate risk prostate cancer
Stereotactic body radiotherapy induced high rates of biochemical control and low rates of severe toxicity among men with low- or... Read More
Use of Conservative Management for Low-Risk Prostate Cancer ‘Increasing Rapidly’
Conservative management or deferred treatment is the preferred approach for men with low-risk prostate cancer, according to results of a... Read More
Nearly 10% of Patients with Prostate Cancer Lost to Follow Up
Almost one in 10 patients with prostate cancer who were under active surveillance were lost to follow up, according to... Read More
Studies of Immunotherapy for Prostate Cancer Yield Encouraging Results
Several studies designed to investigate immunotherapies and immunotherapeutic combinations for treatment of prostate cancer have yielded encouraging results. “Thus far,... Read More